Early hyperbaric oxygen therapy for reducing... (2009 study) Skip to main content
RCT International journal of radiation oncology, biology, physics 2009

Early hyperbaric oxygen therapy for reducing radiotherapy side effects: early results of a randomized trial in oropharyngeal and nasopharyngeal cancer.

Teguh DN, Levendag PC, Noever I, Voet P, van der Est H, van Rooij P, et al., International journal of radiation oncology, biology, physics, 2009

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The researchers randomly assigned 19 people who had radiotherapy for cancers of the throat and nasopharynx to receive hyperbaric oxygen therapy (HBOT) afterward or not, then compared their quality of life and side effects.

What They Found

In this small randomized trial of 19 patients with oropharyngeal and nasopharyngeal cancer, patients who received HBOT after radiotherapy reported better quality of life scores than those who did not, with significant differences in swallowing, dry mouth, sticky saliva, eating in public and mouth pain. HBOT was 30 sessions at 2.5 ATA, with 90 minutes of oxygen breathing daily, 5 days per week, started shortly after radiotherapy ended. The reported p-values were 0.011 for swallowing, 0.009 for dry mouth, 0.01 for sticky saliva, 0.027 for eating in public, and p less than 0.0001 for mouth pain. The abstract reports that better scores were obtained with HBOT on all quality of life items.

What This Means for Canadian Patients

For people facing radiotherapy for throat or nasopharyngeal cancer, this trial reports that those who got HBOT right after radiotherapy rated their swallowing, saliva and mouth pain better than those who did not. These are early results from a small group, so they show an association in this trial and do not tell us how any one person would respond. Anyone considering HBOT should talk with their cancer care team.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

Only 19 patients were randomized, and the abstract describes these as early results, so the findings are limited by the small sample and may change with more patients and longer follow-up.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type RCT
Category Radiation Injury
Source Pubmed
PubMed ID 19386439
Year Published 2009
Journal International journal of radiation oncology, biology, physics
MeSH Terms Adult; Carcinoma, Squamous Cell; Deglutition Disorders; Female; Humans; Hyperbaric Oxygenation; Male; Nasopharyngeal Neoplasms; Oropharyngeal Neoplasms; Quality of Life; Radiation Injuries; Radiotherapy Dosage; Regression Analysis; Time Factors; Trismus

Cite This Study

Share

This study relates to Delayed Radiation Injury. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Radiation Injury

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology